Immunology conference

5 February 2019

 6.25 CME Points Total

Dubai World Trade Centre

Overview:

Theme: Improving clinical outcomes through employing immune-based diagnostics and therapeutics

This conference will provide delegates with a unique opportunity to engage with immunology field experts to discuss the latest trends and important issues concerning the widespread utilisation of immunological techniques for healthcare advancement. Regional and international pioneers within immunology and relevant fields will present their research and share novel case-based knowledge throughout the exclusive scientific programme.

Key topics:

  • Autoimmune diseases
  • Primary immunodeficiency
  • Transplant immunology

Benefits of attending

  • Review the role of immune-based diagnostics and therapeutics for improved clinical practice and appraise the potential and pitfalls
  • Explore immune mechanisms and discuss the cellular responses to viral pathogens
  • Discuss the challenges and potential for the use of immunotherapy as a cancer therapeutic
  • Discover innovative therapeutic options to treat allergies

Chairs:

Gehad Eltayeb ElGhazali, Consultant Physician, Clinical Services - Medical Affairs, Sheikh Khalifa Medical City, Abu Dhabi, UAE

Zain Ali Al Yafei, Senior Clinical Scientist, Clinical Services - Medical Affairs, Sheikh Khalifa Medical City, Abu Dhabi, UAE


Activity Director:

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA


Speaker faculty:

Dr Ali Hajeer, Division Head, Immunopathology Laboratory, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, KSA

Dr Daniele Ielo, Clinical and Scientific Manager, Autoimmunity, Instrumentation, Werfen, Milan, Italy

Dr Gehad Eltayeb ElGhazali, Consultant Physician, Sheikh Khalifa Medical City, Abu Dhabi, UAE

Prof Gulfaraz Khan, Professor, Viral Pathology, Chair, Department of Microbiology & Immunology, College of Medicine, UAE University, Al Ain, UAE

Dr Juliane Brock, Product Manager for Molecular Diagnostics, Euroimmun, Lübeck, Germany

Dr Moheeb Al-Awwami, Clinical Director, Histocompatibility and Immunogenetics Laboratory,
King Faisal Specialist Hospital & Research Centre, Riyadh, KSA

Dr Philipp Arendt, Product Manager for Antigen Diagnostics, Euroimmun, Lübeck, Germany


Accreditation statement:

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 33.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.


Provided by: